Sangam: A Confluence of Knowledge Streams

P-P06 Ward based goal directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: a feasibility randomised controlled trial [ISRCTN 36077283]

Show simple item record

dc.creator Froghi, F
dc.creator Soggiu, F
dc.creator Ricciardi, F
dc.creator Vindrola-Padros, C
dc.creator Floros, L
dc.creator Martin, D
dc.creator Filipe, H
dc.creator Varcada, M
dc.creator Gurusamy, K
dc.creator Bhattacharya, S
dc.creator Fanshawe, A
dc.creator Dolcea, B
dc.creator Mathur, P
dc.creator Davidson, B
dc.date 2022-02-27T12:27:31Z
dc.date 2022-02-27T12:27:31Z
dc.date 2021-12-15
dc.date.accessioned 2022-05-26T21:09:10Z
dc.date.available 2022-05-26T21:09:10Z
dc.identifier http://hdl.handle.net/10026.1/18861
dc.identifier 10.1093/bjs/znab430.230
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/228890
dc.description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Goal directed fluid therapy (GDFT) based on cardiac output assessment has been shown to reduce complications and improve survival for people undergoing major general surgery. There are no reports of cardiac output evaluation being used to optimise the fluid administration for patients with acute pancreatitis who are in a general surgery admission ward.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>The trial protocol has been published. 50 patients with acute pancreatitis were recruited, consented and randomly allocated to either ward-based GDFT with intravenous (IV) fluids administered based on stroke volume optimisation or standard ward care but with blinded cardiac output evaluation for 48 hours following hospital admission.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Over a period of 20 months 50 of 142 screened patients were recruited demonstrating that it was feasible to recruit into a randomised trial of this nature in ward patients with acute pancreatitis. 36 (72%) completed the allocated 48 hours of goal directed fluids with 10 (20%) discharged within 48 hours and 4 withdrawals (3 GDFT and 1 SC).  Baseline characteristics of the groups were similar with only 3 participants having severe disease (6%, 1 GDFT, 2 SC). Similar volumes of IV fluids were administered in both groups (GDFT 5465 (1839) ml, SC 5211 (1745) ml). GDFT group had a lower heart rate, blood pressure and respiratory rate and improved oxygen saturations. GDFT was not associated with any harms. Complications of AP appear to be similar as was duration of stay in intensive care. Length of hospital stay was 5 (2.9) in GDFT and 6.3 (7.6) in SC groups.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Ward GDFT is feasible and shows a signal of possible efficacy in acute pancreatitis in this early-stage study. A larger multi-site RCT is required to confirm clinical and cost effectiveness.</jats:p> </jats:sec>
dc.language en
dc.rights Not known
dc.title P-P06 Ward based goal directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: a feasibility randomised controlled trial [ISRCTN 36077283]
dc.type Presentation


Files in this item

Files Size Format View
Revised Manuscript COLT graft - FF 28-12-21.docx 614.6Kb application/vnd.openxmlformats-officedocument.wordprocessingml.document View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse